Scholars@Duke

Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer.

Publication ,  Journal Article
Tu, W-L; Wang, M-E; Chen, M
Published in: Clin Transl Discov
August 2024
Published version (DOI) Open Access Copy (Duke) Link to item

Duke Scholars

Ming Chen
Author Ming Chen Pathology

Published In

Clin Transl Discov

DOI

10.1002/ctd2.345

EISSN

2768-0622

Publication Date

August 2024

Volume

4

Issue

4

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tu, W.-L., Wang, M.-E., & Chen, M. (2024). Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer. Clin Transl Discov, 4(4). https://doi.org/10.1002/ctd2.345
Tu, Wei-Ling, Mu-En Wang, and Ming Chen. “Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer.” Clin Transl Discov 4, no. 4 (August 2024). https://doi.org/10.1002/ctd2.345.
Tu W-L, Wang M-E, Chen M. Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer. Clin Transl Discov. 2024 Aug;4(4).
Tu, Wei-Ling, et al. “Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer.” Clin Transl Discov, vol. 4, no. 4, Aug. 2024. Pubmed, doi:10.1002/ctd2.345.
Tu W-L, Wang M-E, Chen M. Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer. Clin Transl Discov. 2024 Aug;4(4).

Published In

Clin Transl Discov

DOI

10.1002/ctd2.345

EISSN

2768-0622

Publication Date

August 2024

Volume

4

Issue

4

Location

United States